6月28日，在青创成立12周年之际，一场关于"老字号新出海"的签约仪式引发行业关注。拥 有240多年历史的中华老字号童涵春堂与青创旗下"创选"平台达成战略合作，联合推出国潮 养生茶系列，标志着中国传统品牌正以全新模式加速全球化布局。 老字号新出海：携手创选让世界爱上中国品牌 创立于1783年的童涵春堂(隶属复星国际00656.HK)，是中医药文化的重要传承者。在全球化 浪潮下，这家百年老字号面临新课题：既要坚守传统精髓，又要赢得年轻消费群体。"选择 创选，就是选择了一条'老字号年轻化'的捷径。"童涵春堂负责人表示。此次跨界合作，标志 着这家百年老字号正以崭新姿态拥抱年轻消费群体。 童涵春堂选择与创选合作，正是看中创选在品牌年轻化与全球化方面的双重优势。一方面， 创始人张萌的直播间作为"海外品牌中国第一站"，已成功助力加拿大拉曼益生菌、美国 Nutrafol、西班牙Bechi等数十个海外品牌打开中国市场，另一方面，张萌通过孵化海外华人 IP、运营小红书头部账号等，构建了直达年轻消费者的内容生态。 论坛邀请到香港中文大学商学院副院长、管理学教授马旭飞，科特勒咨询集团全球合伙人、 大中华及新加坡CEO曹虎，以及《一 ...

Group 1: Chili Pepper Industry in Jiangxi - Jiangxi's chili pepper industry, particularly in Gao'an, has seen significant growth, with an annual planting area of approximately 15,000 acres and a production volume of around 60,000 tons, generating a total output value of about 360 million yuan [1][3] - The implementation of an innovative model involving government guidance, village investment, cooperative operation, and farmer participation has improved the chili pepper supply chain, addressing previous challenges such as product variety and market access [3][4] - The Gao'an chili pepper industry park has created over 300 jobs in surrounding towns and is projected to see a 30% increase in production in 2024, with purchase prices doubling [3][4] Group 2: Traditional Chinese Medicine Industry in Jiangxi - The Renhe Group in Zhangshu City has successfully integrated traditional Chinese medicine with modern health products, achieving significant sales growth, with some products exceeding 100 million yuan in annual sales [5][7] - The company has adapted traditional formulations into more convenient forms, such as tablets and capsules, while reducing sugar content to cater to modern consumer preferences [5][8] - Jiangxi's traditional Chinese medicine industry has established itself as a leading sector in the central region, with a total sales revenue of 16.75 billion yuan in 2024, reflecting a year-on-year growth of 6.42% [8][9]

从兰州街头摊贩叫卖的泰国金枕榴莲，到马来西亚市场热销的甘肃礼县柑橘，中国西北内陆省份甘肃与 东盟国家在农产品贸易、中医药、文旅等多个领域碰撞出火花。 6日至10日，第31届中国兰州投资贸易洽谈会举办。在主宾国印尼展销区，手工艺品和咖啡畅销；泰国 展区的清凉油、青草药，柬埔寨的风味虾片，受到消费者追捧…… "我们根据双方消费习惯挑选适销商品，甘肃苹果、高原夏菜、中药材在东盟很有潜力。"甘肃驻马来西 亚商务代表处首席代表马玉田9日接受中新社记者采访时说，通过"甘香丝路，食联南洋"等推介会，已 有多项农贸协议落地，"环球撮合荟"马来西亚国别馆更成为甘肃农产品的海外展示窗口。 在泰国，甘肃驻泰国商务代表处首席代表虎炎正推动中医药文化落地生根。据她介绍，首批21名泰国学 员已毕业，甘肃中医药大学(曼谷)敦煌医学科在泰国设立，两位甘肃中医专家即将赴泰开展临床教学， 让针灸等中医疗法惠及更多当地民众。 柬埔寨甘肃商会会长火照国则忙着为家乡特产"牵线"。"甘肃的洋葱、宽粉、中草药在东南亚很受欢 迎，莫高窟与吴哥窟的文旅对接也大有可为。"他说，希望推动双方在农业、文旅领域深度合作。 另悉，2024年甘肃入境游客同比增长137% ...

Core Insights - The emergence of traditional Chinese medicine (TCM) night markets in Xinxiang has integrated TCM services into local community life, enhancing public awareness of TCM culture [1][2][3] Group 1: TCM Night Market Activities - The TCM night market in Huojia County features four main components: expert consultations, therapy experiences, intangible cultural heritage displays, and food and medicine tasting, attracting long queues of visitors [1] - In Weihu City, the "Health Night Market" offers traditional TCM therapy experiences and herbal soups, which are particularly popular among children and the elderly [2] - Fengquan District's "Midsummer Night Health" event combines TCM and Western medicine services, creating a comprehensive health service system that includes medication guidance and lifestyle interventions [2] Group 2: Community Engagement and Economic Impact - The TCM night market has become a new social landmark for residents, fostering community interactions and increasing health awareness from disease treatment to prevention [3] - The presence of TCM night markets has significantly boosted local economies, with surrounding food stalls and creative shops experiencing daily revenue increases of over 60% due to the influx of visitors [2]

Core Viewpoint - The integration of traditional Chinese medicine (TCM) into elderly care is essential, but there are significant gaps in the grassroots professional service network that need to be addressed through legislation and standardization [1][4]. Group 1: Current State of Elderly Care - Over 90% of elderly individuals in China prefer home-based care, yet there is a lack of accessible community health services, particularly in first and second-tier cities [1]. - The "long-term care insurance model" in Nantong is gaining attention as it creates a care network for disabled elderly individuals through a shared responsibility mechanism involving government, insurance, and individuals [1]. Group 2: Legislative and Policy Recommendations - Experts advocate for the establishment of specific laws such as the "Elderly Care Service Law" and the "Long-term Care Insurance Law" to ensure TCM services are included in long-term care projects [1]. - There is a call for the development of a comprehensive legal framework to protect traditional knowledge and regulate TCM practices, including the standardization of TCM preparation processes [2][3]. Group 3: Integration of TCM in Elderly Care - The integration of TCM into daily life is being promoted through local legislation, such as the "Nanjing Regulation on Promoting the Inheritance and Innovation of TCM," which encourages the concept of "food and medicine sharing the same source" [2]. - Collaborative efforts among academia, government, and industry are being emphasized to create a systematic approach to elderly care that incorporates TCM [3]. Group 4: Global Perspectives and Future Directions - The experience of Australia in achieving legal equality between TCM and Western medicine serves as a reference point for China, which faces more complex challenges but also has the advantage of integrating TCM into national economic strategies [4]. - The revision of the "TCM Law" in the context of an aging population is seen as a crucial step in shaping a unique elderly care system in China, emphasizing the need for legal and standard frameworks to support TCM as a backbone of health in an aging society [4].

Core Insights - Good Doctor Group's project "Interpreting the Scientific Connotation of Traditional Chinese Medicine and Promoting New Drug Research and Development" won the "2025 Excellent Case of Social Responsibility in China's Pharmaceutical Industry" at the 42nd National Pharmaceutical Industry Information Annual Conference, highlighting its commitment to innovation and responsibility in traditional Chinese medicine [1] Group 1: Research and Development - The chairman of Good Doctor Group, Geng Funeng, proposed the "Four Questions of Traditional Chinese Medicine," providing a research framework for the industry [3] - The company has established partnerships with over 20 universities to create a comprehensive innovation system from genomics research to clinical transformation [3] - Good Doctor Group's core product, Kangfuxin Liquid, has been developed over 20 years and is recognized for its efficacy in wound healing, with annual sales exceeding 1 billion yuan [5] Group 2: Intellectual Property and Achievements - Good Doctor Group holds over 2,000 registered trademarks and has received 460 national patents, including 6 original class new drugs with international PCT patents [6] - The company has been awarded multiple national and provincial honors for its research and innovation efforts [6] Group 3: Social Responsibility and Community Engagement - Good Doctor Group is committed to public health, publishing a series of books on the medicinal benefits of the American cockroach and Kangfuxin Liquid to educate the public [6] - The company has developed the Good Doctor Cloud Medical Platform, connecting over 600,000 grassroots medical institutions to enhance healthcare accessibility [6] Group 4: Future Directions - Good Doctor Group aims to continue leveraging the "Four Questions of Traditional Chinese Medicine" to accelerate drug development and international expansion, revitalizing traditional Chinese medicine through modern technology [7]

Group 1 - The article emphasizes the limitations of AI in the medical field, particularly in capturing the nuances of human emotions and individual differences, highlighting the value of traditional Chinese medicine (TCM) in addressing these gaps [1] - TCM's holistic approach, focusing on concepts like "Qi," "Yin-Yang," and "meridians," is presented as a complementary solution to modern medical practices, especially in the area of preventive care [1] - The company, Kangchi Health Industry Group, is committed to the inheritance and modernization of TCM, aiming to enhance cultural confidence and national identity through a multi-dimensional TCM ecosystem [1] Group 2 - Data shows that the configuration rate of AI-assisted tongue and pulse diagnosis devices in TCM clinics has reached 73%, promoting standardization in grassroots TCM practices [2] - The Kangchi Yisheng APP, developed by Kangchi Group, integrates AI with TCM diagnostics, allowing for rapid and accurate health assessments based on tongue images, thus providing objective diagnostic support for practitioners [2] - The APP also compiles a vast knowledge graph of TCM clinical cases, enabling AI-assisted systems to offer diverse diagnostic and treatment options, significantly improving efficiency and accuracy in patient care [2] Group 3 - In the AI era, the health sector is calling for diverse and integrated solutions, with Kangchi Group leveraging technology to preserve TCM heritage and drive its development [3] - The company is focused on creating a comprehensive ecosystem that encompasses smart diagnostics, educational innovations, and the management of the entire TCM industry chain [3] - Kangchi Group aims to ensure that every health decision made in the AI era is informed by a profound understanding of life, ensuring the continuity of TCM wisdom [3]

Core Viewpoint - The integration of traditional Chinese medicine culture with modern night market economy is creating unique experiences for citizens, enhancing cultural tourism during the summer season [1][2]. Group 1: Event Overview - The third "Da Song Traditional Chinese Medicine Culture Market" was held in Kaifeng, allowing citizens to experience various traditional Chinese medicine practices and receive expert medical consultations [1]. - The event aims to promote traditional Chinese medicine culture and enrich the summer cultural tourism market, focusing on "inheritance, experience, and health" [1]. Group 2: Government Initiatives - In January 2023, the State Council issued measures to cultivate new growth points and promote cultural and tourism consumption, emphasizing the development of night economy [1]. - Various regions are exploring diverse night economy formats, including traditional Chinese medicine night markets, to invigorate local economies [1]. Group 3: Regional Developments - Other provinces such as Shandong, Liaoning, and Sichuan have also hosted traditional Chinese medicine night markets, featuring activities like medicinal cuisine preparation and acupuncture workshops to attract younger audiences [1].

Core Viewpoint - The company, Panlong Pharmaceutical, has transformed from a near-bankrupt small factory into a nearly 10 billion yuan traditional Chinese medicine listed enterprise over 27 years, focusing on high-quality development and a comprehensive health strategy [1] Group 1: Corporate Governance and Development Strategy - The company integrates party building into its governance structure, with all board members being party committee members, ensuring that the party organization has real power in strategic decision-making [2] - The unique "12345" party building model has led to significant operational improvements, including a 40% efficiency increase in tablet production lines and over 10 million yuan in annual cost savings [2] - The company has achieved a 45.28% growth in main business revenue and a 47.89% increase in net profit over the past five years, with R&D investment consistently exceeding 6% [2] Group 2: Product and Market Development - In 2024, the company's self-produced traditional Chinese medicine generated revenue of 645 million yuan, a year-on-year increase of 10.20%, with its revenue share rising from 59.67% to 66.22% [4] - The company aims to become a leading player in the Chinese herbal formula granules market, targeting over 400 products for production and sales [4] Group 3: Social Responsibility and Community Engagement - The company has implemented a "Five Guarantees Poverty Alleviation Model," resulting in an average annual income increase of 24,000 yuan for 7,520 households [5][6] - Panlong Pharmaceutical has established a 100 million yuan charitable fund and has been recognized as a national green factory, contributing to local economic development and social welfare [6] Group 4: Future Outlook - The company plans to deepen its "one body, two wings, three depths" development strategy by focusing on orthopedic chronic diseases and enhancing its product matrix across various therapeutic areas by 2025 [7]

Core Viewpoint - Beijing aims to accelerate the development of the "Artificial Intelligence + Healthcare" sector, establishing itself as an international innovation hub by 2027 through a comprehensive action plan [3][4]. Group 1: Development Goals - Leverage Beijing's advantages in AI technology, medical resources, and health data to create a dual innovation and application ecosystem in the "Artificial Intelligence + Healthcare" industry by 2027 [4]. - Achieve the transformation of over 30 core technologies and innovative products, with at least 20 innovative drugs and medical devices entering clinical trials [4]. - Promote the application of AI in various healthcare scenarios, including medical services and public health, with a focus on at least 10 specific applications [4]. Group 2: Key Tasks - **Basic Research Breakthroughs**: Explore new paradigms in life sciences driven by AI, focusing on foundational theories and algorithms [6]. - **Data Resource Construction**: Accelerate the establishment of a comprehensive health information platform to integrate various health data sources [8]. - **AI Empowerment in Healthcare**: Support the development of AI applications in drug discovery, personalized medicine, and smart healthcare services [10][11]. Group 3: Innovation Ecosystem - Establish innovation incubators and accelerate platforms to enhance the efficiency of transforming innovative results into practical applications [17]. - Foster collaboration among medical, industrial, academic, and research entities to create competitive industry clusters [5][19]. - Develop a technical standard system to ensure the reliability and compatibility of AI healthcare products [16]. Group 4: Support Measures - Utilize the city's medical health coordination mechanism to ensure effective service and support for key areas [21]. - Encourage investment from various social capital sources to boost innovation in the healthcare sector [21]. - Attract top scientists and teams to enhance talent cultivation in the AI healthcare field [21].